Cover Image
市場調查報告書

Opioids(類鴉片物質)引起的腸功能障礙:全球臨床實驗檢討

Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 299744
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
Opioids(類鴉片物質)引起的腸功能障礙:全球臨床實驗檢討 Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 53 Pages
簡介

本報告提供Opioids(類鴉片物質)引起的腸功能障礙治療藥的相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,各階段及Phase別狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中Opioids(類鴉片物質)引起的腸功能障礙的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:腫瘤科臨床實驗中Opioids(類鴉片物質)引起的腸功能障礙的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 參與Opioids(類鴉片物質)引起的腸功能障礙的治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Cubist Pharmaceuticals, Inc.
    • Salix Pharmaceuticals Ltd.
    • Sucampo Pharmaceuticals, Inc.
    • 鹽野義製藥
    • Helsinn Holding S.A.
  • 主要大學·研究機關·醫院臨床實驗概要
    • 橫?市立大學附屬醫院
    • Mech-Sense
    • Kuopio University Hospital

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3819CTIDB

GlobalData's clinical trial report, "Opioid-Induced Bowel Dysfunction (OBD or OIBD) Global Clinical Trials Review, H2, 2016" provides an overview of Opioid-Induced Bowel Dysfunction (OBD or OIBD) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Bowel Dysfunction (OBD or OIBD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials by E7 Countries: Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Region, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, G7 Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, E7 Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, G7 Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Proportion of Opioid-Induced Bowel Dysfunction (OBD or OIBD) to Toxicology Clinical Trials, E7 Countries (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top